Residential magnetic fields, medication use, and the risk of breast cancer

Epidemiology

Volumn 18, Issue 2, 2007, Pages 266-269

  Davis, Scott ^a,b   Mirick, Dana K ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; MELATONIN; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PSYCHOSTIMULANT AGENT; TRANQUILIZER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RISK; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; INTERVIEW; MAGNETIC FIELD; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; NIGHT SLEEP; PRIORITY JOURNAL; RESIDENTIAL HOME; TELEPHONE;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; DRUG THERAPY; ELECTRIC WIRING; ELECTROMAGNETIC FIELDS; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MELATONIN; MIDDLE AGED; ODDS RATIO; RESIDENCE CHARACTERISTICS; RISK ASSESSMENT; WASHINGTON;

EID: 33847053958     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ede.0000253934.58618.98     Document Type: Article

References (20)

1. Stevens RG. Electric power use and the risk of breast cancer: a hypothesis. Am J Epidemiol. 1987;125:556-561.
2. Davis S, Mirick DK, Stevens RG. Residential magnetic fields and the risk of breast cancer. Am J Epidemiol. 2002;155:455-462.
3. Davis S, Kaune WT, Mirick DK, et al. Residential magnetic fields, light-at-night, and nocturnal urinary 6-sulfatoxymelatonin concentration in women. Am J Epidemiol. 2001;154:591-600.
4. Davis S, Mirick DK, Stevens RG. Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst. 2001;93:1557-1562.
5. Breslow NE, Day NE. Statistical Methods in Cancer Research. Vol 1. The Analysis of Case-Control Studies. (IARC Scientific Publication no. 32). Lyon, France: International Agency for Research on Cancer; 1980.
6. Beck-Friis J, von Rosen D, Kjellman BF, et al. Melatonin in relation to body measures, sex, age, season, and the use of drugs in patients with major affective disorders and healthy subjects. Psychoneuroendocrinology. 1984;9:261-277.
7. Yen SSC. Chronic anovulation due to CNS-hypothalamic-pituitary dysfunction. In: Yen SSC, Jaffe RB, eds. Reproductive Endocrinology, 3rd ed. Philadelphia: W.B. Sanders; 1991:631-689.
8. Reiter RJ, ed. The Pineal Gland. Vol I. Boca Raton, FL: CRC Press; 1981.
9. Schoenfeld ER, O'Leary ES, Henderson K, et al. Electromagnetic fields and breast cancer on Long Island: a case-control study. Am J Epidemiol. 2003;158:47-58.
10. London SJ, Pogoda JM, Hwang KL, et al. Residential magnetic field exposure and breast cancer risk: a nested case-control study from a multiethnic cohort in Los Angeles County, California. Am J Epidemiol. 2003;158:969-980.
11. Kabat GC, O'Leary ES, Schoenfeld ER, et al. Electric blanket use and breast cancer on Long Island. Epidemiol. 2003;14:514-520.
12. Forssen UM, Rutqvist LE, Ahlbom A, et al. Occupational magnetic fields and female breast cancer: a case-control study using Swedish population registers and new exposure data. Am J Epidemiol. 2005;161:250-259.
13. Caplan LS, Schoenfeld ER, O'Leary ES, et al. Breast cancer and electromagnetic fields - a review. Ann Epidemiol. 2000;10:31-44.
14. Brainard GC, Kavet R, Kheifets LI. The relationship between electromagnetic field and light exposures to melatonin and breast cancer risk: a review of the relevant literature. J Pineal Res. 1999;26:65-100.
15. Graham C, Cook MR, Riffle DW, et al. Nocturnal melatonin levels in human volunteers exposed to intermittent 60 Hz magnetic fields. Bioelectromagnetics. 1996;17:263-273.
16. Graham C, Cook MR, Riffle DW. Human melatonin during continuous magnetic field exposure. Bioelectromagnetics. 1997;18:166-171.
17. McIntyre IM, Norman TR, Burrows GD, et al. Human melatonin suppression by light is intensity dependent. J Pineal Res. 1989;6:149-156.
18. McIntyre IM, Norman TR, Burrows GD, et al. Melatonin supersensitivity to dim light in seasonal affective disorder (letter). Lancet. 1990;335:488.
19. Boudreau DM, Daling JR, Malone KE, et al. A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women. Am J Epidemiol. 2004;159:308-317.
20. Schernhammer ES, Hankinson SE. Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst. 2005;97:1084-1087.